Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
BackgroundAllergic bronchopulmonary aspergillosis (ABPA) is an underestimated allergic disease due to Aspergillus fumigatus (AF). The main diagnostic criteria for ABPA rely on the evaluation of immunoglobulin (Ig) E and IgG responses to AF extracts, although these cannot discriminate AF-sensitizatio...
Main Authors: | Moïse Michel, Youssouf Sereme, Farid Mankouri, Marion Gouitaa, Clarisse Gautier, Jean-Louis Mège, Carole Cassagne, Stéphane Ranque, Martine Reynaud-Gaubert, Joana Vitte |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Allergy |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/falgy.2022.898731/full |
Similar Items
-
Ubiquitous Fungus Irking Inclined Wheezers - A succinct on Allergic Bronchopulmonary Aspergillosis
by: Amal Johnson, et al.
Published: (2019-01-01) -
The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA—A Case Series
by: Aoife O’Reilly, et al.
Published: (2021-12-01) -
BASOPHILE ACTIVATION TEST FOR THE DIAGNOSTICS OF FUNGAL SENSITIZATION IN THE PATIENTS WITH CYSTIC FIBROSIS
by: Ya. I. Kozlova, et al.
Published: (2019-12-01) -
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
by: Tjeerd van derVeer, et al.
Published: (2021-12-01) -
Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele
by: Jacky Tu, et al.
Published: (2022-06-01)